-+ 0.00%
-+ 0.00%
-+ 0.00%

ONCE-WEEKLY TRANSCON® CNP (NAVEPEGRITIDE) TO RECEIVE 10 YEARS OF MARKET EXCLUSIVITY UPON APPROVAL IN THE EUROPEAN UNION

Reuters·11/06/2026 13:00:43

Please log in to view news